US Patent 7262203 Pyrimidineamines as angiogenesis modulators
Patent 7262203 was granted and assigned to Smithkline Beecham Limited on August, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 21 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
Amogh Boloor0
James Marvin Veal0
Jeffery Alan Stafford0
Kevin Hinkle0
Mui Cheung0
Philip Anthony Harris0
Robert Anthony Mook, Jr.0
Ronda Davis0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+268 characters)
Article
Patent abstract
Pyrimidine derivatives, which are useful as VEGFR2 inhibitors are described herein. The described invention also includes methods of making such pyrimidine derivatives as well as methods of using the same in the treatment of hyperproliferative diseases.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07262203 Pyrimidineamines as angiogenesis modulators US Patent 7262203 Pyrimidineamines as angiogenesis modulators
Infobox
Patent Number
07262203
Patent Number
7262203
Edits on 16 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 22 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07262203 Pyrimidineamines as angiogenesis modulators
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07262203
Date of patent
August 28, 2007
Patent application number
11383229
Date Filed
May 15, 2006
Patent primary examiner
Find more entities like US Patent 7262203 Pyrimidineamines as angiogenesis modulators
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
